BriaCell Therapeutics Corp - Warrant — Quarterly Balance Sheet (NASDAQ:BCTXZ)

Financials

Total revenue -2 391-12.1 K-1 33620.53 K585-44.72 K20.68 K -2 928 Gross profit -2 391-12.1 K-1 33620.53 K585-44.72 K20.68 K -2 928 Operating expenses 9.23 M5.77 M5.15 M7.17 M6.33 M8.55 M8.32 M 30.37 M Selling/general/admin expenses 1.57 M1.36 M1.49 M1.48 M1.52 M1.44 M1.64 M 6.09 M Research & development 7.66 M4.41 M3.67 M5.68 M4.81 M7.11 M6.68 M 24.29 M Operating income -9.23 M-5.77 M-5.15 M-7.17 M-6.33 M-8.55 M-8.32 M -30.37 M Non-Operating Income, Total 23.67 M-12.1 K11.71 K67.36 K-9 76245.2 K158.65 K 261.44 K Interest expense, net of interest capitalized ————36.98 K—— — Non-Operating Income, excl. Interest Expenses 23.67 M-12.1 K11.71 K67.36 K-46.74 K45.2 K158.65 K 224.46 K Unusual income/expense ——————— — Pretax income 1.69 M4.88 M-5.21 M-7.14 M-6.44 M26.51 M-8.21 M 4.72 M Equity in earnings -37 K-51.17 K-71.52 K-42.58 K-62.74 K-47.38 K-44.83 K -197.53 K Taxes —4.2 M———791.27 K— — Non-controlling/minority interest -23.52 K-34.59 K-27.1 K-46.41 K-98.03 K-72.74 K-80.76 K -297.94 K After tax other income/expense ——————— — Net income before discontinued operations 1.72 M-1.21 M-5.8 M-6.29 M-6.13 M-8.09 M-8.2 M -28.71 M Discontinued operations ——————— — Net income 1.72 M-1.21 M-5.8 M-6.29 M-6.13 M-8.09 M-8.2 M -28.71 M Dilution adjustment ——————— — Preferred dividends ——————— — Diluted net income available to common stockholders 0-1.21 M-5.8 M-6.29 M-6.13 M-8.09 M-8.2 M -28.71 M Basic earnings per share (Basic EPS) 16.5-10.2-33-23.3-16.410.18-4.35 -33.87 Diluted earnings per share (Diluted EPS) 16.5121.8-33-23.3-16.410.18-4.35 -33.87 Average basic shares outstanding 106.54 K109.7 K177.61 K222.5 K271.79 K423.11 K1.88 M 2.8 M Diluted shares outstanding 106.54 K109.7 K177.61 K222.5 K271.79 K423.11 K1.88 M 2.8 M EBITDA ——————— — EBIT ——————— — Cost of revenue ——————— — Other cost of goods sold ——————— — Depreciation & amortization (cash flow) —15.27 K26.66 K——15.27 K26.66 K —